Granese, Barbara (2011) Molecular bases of Down syndrome: differential gene expression and pathway dysregulation associated with trisomy 21. [Tesi di dottorato] (Unpublished)

[img]
Preview
PDF
barbara_granese.pdf

Download (3MB) | Preview
Item Type: Tesi di dottorato
Language: English
Title: Molecular bases of Down syndrome: differential gene expression and pathway dysregulation associated with trisomy 21
Creators:
CreatorsEmail
Granese, Barbarabarbaragranese@yahoo.it
Date: 30 November 2011
Number of Pages: 110
Institution: Università degli Studi di Napoli Federico II
Department: Pediatria
Doctoral School: Medicina clinica e sperimentale
PHD name: Riproduzione, sviluppo ed accrescimento dell'uomo
PHD cycle: 24
PHD Coordinator:
nameemail
Pignata, ClaudioUNSPECIFIED
Tutor:
nameemail
Generoso, AndriaUNSPECIFIED
Date: 30 November 2011
Number of Pages: 110
Uncontrolled Keywords: Down syndrome, proteasome, NFAT
MIUR S.S.D.: Area 06 - Scienze mediche > MED/38 - Pediatria generale e specialistica
Date Deposited: 07 Dec 2011 11:33
Last Modified: 17 Jun 2014 06:04
URI: http://www.fedoa.unina.it/id/eprint/8788

Abstract

Down syndrome (DS) is known to be a complex disorder caused by trisomy of either the entire or a critical portion of chromosome 21 (21q22.1-22.3), but the pathophysiologic bases of the clinical DS phenotypes are still obscure. A previous genome-wide analysis performed on DS and euploid lymphoblastoid cell lines, allowed us to identify genes and pathways dysregulated in DS subjects with the aim to expand the knowledge on the molecular bases of DS and to provide new tools for the development of innovative therapeutic approaches. Our results identified ubiquitin mediated proteolysis as the pathway most influenced by trisomy 21, whereas ubiquitin metabolism and regulation of NFkappaB cascade resulted to be two of the most significant down regulated GO categories. On the basis of these results and of the data present in the literature, we analyzed, both to validate microarray data and to investigate their role in DS pathogenesis: the ubiquitin-proteasome system (UPS); the NFkappaB pathway and the DYRK1A/DSCR1/NFAT pathway. Finally, the sequencing analysis of the MCPH1 gene, a causative gene of primary microcephaly deregulated in our DS subjects, in a population of unrelated patients with primary microcephaly. Results suggested that in DS there is a defective protein degradation system that could result from a primary dysfunction of UPS and from an excess of damaged proteins, and in agreement a down-regulation of the NF-kappaB cascade, a model protein regulated by ubiquitination. Finally, also the NFAT pathway resulted deregulated with the overexpression of the two chr21 genes, DYRK1A and DSCR1, and a significant reduction of NFATc2 and its nuclear export. In conclusion, the present study provides evidence of multiple and linked biological processes that have the rational to be directly involved in DS. Therefore, further analyses of these altered genes and pathways could be taken into account

Actions (login required)

View Item View Item